The repeat experiment with an increased number of animals (n = 9) also confirmed that the low dose of SRC-3 KO Tregs (1: 230K cells, 3: 314K cells, 3: 358K cells) did not eradicate breast tumors compared to the high dose of SRC-3 KO Tregs (Fig. 5C). Here, NCOA3 is linked to breast neoplasm.